What is Carboplatin?

Category: Prescription Drugs

false

See also: Docetaxel-carboplatin-trastuzumab-pertuzumab Docetaxel-carboplatin-trastuzumab (TCH) ICE regimen

Carboplatin is chemotherapy agent often used to treat ovarian cancer. It may also be used to treat a variety of other cancers including lung, head and neck, endometrial, esophageal, bladder, breast, cervical, central nervous system tumors, and germ cell tumors.

Find patients like you who take Carboplatin

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Ovarian cancer 18 9
Lung cancer 7 2
Endometrial cancer 4 7
Breast cancer 1 0
Esophageal cancer 1 0

Show all 9 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 5
Moderate 3
Mild 7
None 6

Commonly reported side effects and conditions associated with Carboplatin

Side effect Patients
Nausea 5
Fatigue 3
Hair loss 3
Neuropathy 3
Anemia 2
Peripheral neuropathy 2

Show all 18 reported side effects

Dosages

Based on patients currently taking Carboplatin

Dosage Patients
0.05 g every 3 weeks 1
10 mg every 3 weeks 1
545 mg every 3 weeks 1

Why patients stopped taking Carboplatin

Multiple reasons could be selected

Reason Patients
Course of treatment ended 15
Doctor's advice 3
Did not seem to work 1
Other 1
Side effects too severe 1
See all 19 patients who've stopped taking Carboplatin

Duration

Currently taking Carboplatin

Duration Patients
1 - 6 months 1
1 - 2 years 2
2 - 5 years 1

Stopped taking Carboplatin

Duration Patients
Less than 1 month 1
1 - 6 months 14
6 months - 1 year 3
1 - 2 years 1
Adherence
Adherence Evaluations
Always 17
Usually 3
Sometimes 0
Never taken as prescribed 1
Burden
Burden Evaluations
Very hard to take 2
Somewhat hard to take 5
A little hard to take 4
Not at all hard to take 10
Cost per month
Cost per month Evaluations
$200+ 2
$100-199 0
$50-99 0
$25-49 0
< $25 13
Not specified 6

What people switch to and from

Patients stopped taking Carboplatin and switched to:

Treatment Patients
Bevacizumab (Avastin) 1
Last updated:
There are no evaluations for Carboplatin.